Skip to main content

Heise Lab Partners with Chimerix on New SARS-CoV-2 Therapy

February 28, 2022

The compound CMX521 significantly reduced lung viral titer and symptoms in a SARS-CoV-2 mouse model, as reported by biomedical company Chimerix in collaboration with the Rapidly Emerging Antiviral Drug Development Initiative at UNC-Chapel Hill. UNC School of Medicine faculty Nat Moorman, PhD, and Mark Heise, PhD, are key researchers in this program.

Genetics Department ranks 3rd nationally for NIH Funding

February 22, 2022

The annual Blue Ridge Institute for Medical Research report on NIH Funding to US Medical Schools lists the UNC Chapel Hill Department of Genetics as the 3rd ranked Genetics Department with $44,120,400 in funding.

Laura Raffield, PhD, Awarded R01 from NIA

February 21, 2022

Dr. Laura Raffield (Assistant Professor, Genetics) was awarded a 4-year R01 from the National Institute on Aging (NIA) titled “Immune Cells in Alzheimer’s Disease and Related Dementias in the Jackson Heart Study”.

Katie Hoadley, PhD and Jesse Raab, PhD Receive CEHS Pilot Award

February 9, 2022

Drs. Katie Hoadley and Jesse Raab (Assistant Professors, Genetics) received a Team Science Pilot Project Award from the UNC Center for Environmental Health and Susceptibility (CEHS) for their collaborative project titled “Understanding genetic and environmental drivers of primary liver cancer”.